3,4-dihydroxyphenylacetic acid has been researched along with 5-s-cysteinyldopamine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Carlsson, A; Fornstedt, B | 3 |
Carlsson, A; Fornstedt, B; Pileblad, E | 1 |
Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P | 1 |
Bermejo, MK; Dunn, AR; Fu, R; Goldstein, DS; Gregersen, E; Jensen, PH; Masoud, ST; Miller, GW; Nazari, R; Ramsey, A; Salahpour, A; Sullivan, P; Urs, NM; Vecchio, LM | 1 |
7 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 5-s-cysteinyldopamine
Article | Year |
---|---|
Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Guinea Pigs; Limbic System; Oxidation-Reduction; Pargyline; Reserpine; Time Factors | 1991 |
Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Cerebellum; Corpus Striatum; Dopamine; Female; Guinea Pigs; Limbic System; Norepinephrine | 1991 |
Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catechols; Dopamine; Guinea Pigs; Humans; Oxidation-Reduction; Parkinson Disease; Time Factors | 1991 |
In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Cerebral Cortex; Corpus Striatum; Cysteinyldopa; Dopamine; Female; Glutathione; Guinea Pigs; Oxidation-Reduction | 1990 |
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats | 2016 |
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Catecholamines; Central Nervous System Stimulants; Dopamine; Female; Gene Dosage; Glutathione; Humans; Hydrogen Peroxide; Male; Mice; Mice, Transgenic; Neurons; Oxidative Stress; Tyrosine 3-Monooxygenase | 2021 |